Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-76 of 76 for

Edit search filters
  1. A Study of Blood and Tissue Samples to Measure Immune Responses to Melanoma

    Rochester, MN

  2. Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients

    Rochester, MN

  3. Validation of a Blood Assay for the Detection of BRAF Mutation Status in Patients with Metastatic Melanoma

    Rochester, MN

  4. Melanoma Registry

    Jacksonville, FL

  5. Reporting of Side Effects Among Stage III and IV Melanoma Patients Treated with Immune Checkpoint Inhibitors

    Rochester, MN

  6. Defining the Immunologic Profile of Sentinel Lymph Nodes and Identifying the Mechanisms Responsible for Immunosuppression

    Rochester, MN, Jacksonville, FL

.

Mayo Clinic Footer